Recon: Globus to acquire NuVasive in $3B deal; AstraZeneca seeks growth with new drugs amid falling COVID sales

Recon

ReconMichael Mezher

Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy